Bluezone Insurance launches dedicated Type 2 Diabetes cover

First life insurance policy goes live

John Brazier
clock • 2 min read

Bluezone Insurance has gone live with its first life insurance proposition, designed specifically for consumers with Type 2 diabetes.

The policy is aimed at offering cover to a segment of customers that have previously been unable to secure life insurance due to the condition, as well as "removing lengthy form filling and required medical appointments previously needed to secure a similar policy." Bluezone stated that the launch comes at "a critical time" as there are more than four million people in the UK that have been diagnosed with Type 2 diabetes, with a further one million people unaware that they are living with a chronic illness. Speaking to COVER last year, Dr Karan Mehta, co-founder and chief executive of...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

The COVER Review: NHS waiting list, provider updates and over-insurance

The COVER Review: NHS waiting list, provider updates and over-insurance

Week commencing 10 February 2025

COVER
clock 14 February 2025 • 1 min read
Two-thirds of parents worried about critical illness for children

Two-thirds of parents worried about critical illness for children

Findings from third LV= Reaching Resilience report

Jaskeet Briah
clock 13 February 2025 • 1 min read
NHS waiting list hits low in December

NHS waiting list hits low in December

7.48 million people awaiting treatment

Jaskeet Briah
clock 13 February 2025 • 1 min read